SpencerZRoseroMD
Cardiology • Rochester, NYCardiac Electrophysiology
Interim Chief of Cardiology, Professor of Medicine, University of Rochester School of Medicine & Dentistry
Dr. Rosero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-4775
Education & Training
University of RochesterFellowship, Clinical Cardiac Electrophysiology, 1998 - 2000- University of RochesterFellowship, Cardiovascular Disease, 1995 - 2000
- University of RochesterResidency, Internal Medicine, 1993 - 1995
State University of New York Downstate Medical Center College of MedicineClass of 1993
Certifications & Licensure
NY State Medical License 1994 - 2026- American Board of Internal Medicine Clinical Cardiac Electrophysiology
- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients Start of enrollment: 2012 Sep 01
- Study of the Effect of GS-6615 in Subjects With LQT-3 Start of enrollment: 2013 May 01
- OptiVol for Precision Medical Management of Heart Failure Start of enrollment: 2020 Feb 05
Publications & Presentations
PubMed
- 3 citationsPrimary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease.Ido Goldenberg, Valentina Kutyifa, Wojciech Zareba, David Tsu-Chau Huang, Spencer Z Rosero
Frontiers in Cardiovascular Medicine. 2023-01-01 - 18 citationsMexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.Chad Heatwole, Elizabeth Luebbe, Spencer Rosero, Katy Eichinger, William B. Martens
Neurology. 2020-10-12 - 89 citationsSafety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.Arthur J. Moss, John R. Windle, W. Jackson Hall, Wojciech Zareba, Jennifer L Robinson
Annals of Noninvasive Electrocardiology. 2005-10-01
Press Mentions
Caring Buffalo Nurse Receives New Heart, Second ChanceJuly 11th, 2022- URMC Part of Collaboration Awarded $10M for Pediatric Concussion ResearchOctober 11th, 2021
Of Fact, Fiction and DefibrillatorsOctober 27th, 2013- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
